EBV DNA DETECTION BY PCR (BLOOD)

The EBV DNA Detection by PCR (Blood) is a molecular diagnostic test that identifies and quantifies Epstein–Barr virus (EBV) genetic material in a patient's blood using real-time PCR technology. It measures viral DNA levels (viral load), allowing clinicians to determine active viral replication rather than past exposure detected by antibodies. This test is particularly valuable when serology is inconclusive or when timely detection of active infection is required.

This assay is commonly used to diagnose suspected acute EBV infection (including infectious mononucleosis), to monitor EBV reactivation in immunocompromised or transplant patients, and to guide clinical decisions for antiviral therapy or further specialist referral. Home blood collection is available across Dubai and the UAE, enabling convenient sampling for patients who require rapid, reliable results without visiting a clinic or hospital.

Sample requirements and interpretation should be discussed with the ordering physician: the test typically requires venous blood collected in appropriate tubes (e.g., EDTA or plasma), and results must be interpreted in the clinical context since low-level DNA can occasionally reflect latent infection. Inform your clinician about recent antivirals or immunosuppressive therapy, and ensure correct patient identification (Emirates ID) for home collection and lab processing.

• EBV DNA (Quantitative viral load)
• EBV DNA (Qualitative detection: detected / not detected)
• Sample type: Whole blood / Plasma
• Method: Real-time PCR

• Symptoms of infectious mononucleosis (fever, sore throat, lymphadenopathy)
• Suspected EBV reactivation in immunocompromised or transplant patients
• Unexplained persistent fever or lymphadenopathy
• Monitoring response to antiviral therapy for EBV-associated disease
• Evaluation of suspected EBV-related complications (e.g., post-transplant lymphoproliferative disorder)

• Accurate detection of active EBV infection via molecular testing
• Quantitative viral load helps monitor disease activity and treatment response
• Rapid and sensitive real-time PCR methodology
• Convenient home blood collection across Dubai and the UAE
• Clinical-grade reporting to support timely physician decision-making

• At-home venous blood collection by a certified phlebotomist (EDTA/plasma tube)
• No fasting required; follow any medication guidance from your physician
• Provide valid Emirates ID and a confirmed Dubai/UAE address for collection
• Inform the team of recent antiviral or immunosuppressive treatments before sampling